يعرض 1 - 10 نتائج من 17 نتيجة بحث عن '"Morten Mau-Sorensen"', وقت الاستعلام: 0.96s تنقيح النتائج
  1. 1
    Data from Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity

    المؤلفون: Ulrik N. Lassen, Martin Weisser, Birgit Bossenmaier, Francesca Michielin, Celine Adessi, Lori Steiner, Maitram Nguyen, Rajiv Dua, Suzana Vega-Harring, Ian James, Georgina Meneses-Lorente, Maurizio Ceppi, Marlene Thomas, Sabine Wilson, Jan H.M. Schellens, Sang-We Kim, Enriqueta Felip, Antonio Calles, Ji-Youn Han, Stefan Sleijfer, Maja J. De Jonge, Marlies H.G. Langenberg, Martijn P. Lolkema, Andres Cervantes, Tania Fleitas, Alvaro Taus, Maria Martinez-Garcia, Morten Mau-Sorensen, Emile E. Voest, Wolfgang Jacob, Didier Meulendijks

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::318985d039f3af8aedc62fa7c6e52f8e
    https://doi.org/10.1158/1078-0432.c.6527064.v1

    أضف إلى المفضلة
  2. 2
    Table S1, Table S2 from Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity

    المؤلفون: Ulrik N. Lassen, Martin Weisser, Birgit Bossenmaier, Francesca Michielin, Celine Adessi, Lori Steiner, Maitram Nguyen, Rajiv Dua, Suzana Vega-Harring, Ian James, Georgina Meneses-Lorente, Maurizio Ceppi, Marlene Thomas, Sabine Wilson, Jan H.M. Schellens, Sang-We Kim, Enriqueta Felip, Antonio Calles, Ji-Youn Han, Stefan Sleijfer, Maja J. De Jonge, Marlies H.G. Langenberg, Martijn P. Lolkema, Andres Cervantes, Tania Fleitas, Alvaro Taus, Maria Martinez-Garcia, Morten Mau-Sorensen, Emile E. Voest, Wolfgang Jacob, Didier Meulendijks

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::804d643b37a2cdf6fd277ce1fd5c048c
    https://doi.org/10.1158/1078-0432.22468827

    أضف إلى المفضلة
  3. 3
    Supplemental Figure S1 and Table S1 from A Phase I Monotherapy Study of RG7212, a First-in-Class Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Cancers

    المؤلفون: Glenwood D. Goss, Mark DeMario, Ka Wang, David Geho, Tiantom Jarutat, Suzana M. Vega-Harring, Markus Roessler, Hua Zhong, Dean Bottino, Kathleen J. Schostack, Mary E. Simcox, Aaron R. Hansen, Derek J. Jonker, Jan H.M. Schellens, Morten Mau-Sorensen, Vaios Karanikas, Lilian L. Siu, Didier Meulendijks, Ulrik N. Lassen

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e0ab408c3772903e1549f808a8c8771
    https://doi.org/10.1158/1078-0432.22460889.v1

    أضف إلى المفضلة
  4. 4
    Supplemental table 1 from A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple Myeloma

    المؤلفون: Guido Tricot, Martine Poelman, Magnus Korsgren, Björn Frendeus, Maurizio Zangari, Stina Wichert, Jan Van Droogenbroeck, Ingrid Teige, Annika Sundberg, Yvonne Stenberg, Morten Mau-Sorensen, Elisabeth Sonesson, Morten Salomo, Fritz Offner, Hareth Nahi, Titti Martinsson Niskanen, Ashraf Badros, Peter Gimsing, Markus Hansson

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a13375faa4934a754b2d055a8470def8
    https://doi.org/10.1158/1078-0432.22461654

    أضف إلى المفضلة
  5. 5
    Data from A Phase I Monotherapy Study of RG7212, a First-in-Class Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Cancers

    المؤلفون: Glenwood D. Goss, Mark DeMario, Ka Wang, David Geho, Tiantom Jarutat, Suzana M. Vega-Harring, Markus Roessler, Hua Zhong, Dean Bottino, Kathleen J. Schostack, Mary E. Simcox, Aaron R. Hansen, Derek J. Jonker, Jan H.M. Schellens, Morten Mau-Sorensen, Vaios Karanikas, Lilian L. Siu, Didier Meulendijks, Ulrik N. Lassen

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f1556d4bf5a8a7e541e0458a0379e4b
    https://doi.org/10.1158/1078-0432.c.6524631

    أضف إلى المفضلة
  6. 6
    Data from A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple Myeloma

    المؤلفون: Guido Tricot, Martine Poelman, Magnus Korsgren, Björn Frendeus, Maurizio Zangari, Stina Wichert, Jan Van Droogenbroeck, Ingrid Teige, Annika Sundberg, Yvonne Stenberg, Morten Mau-Sorensen, Elisabeth Sonesson, Morten Salomo, Fritz Offner, Hareth Nahi, Titti Martinsson Niskanen, Ashraf Badros, Peter Gimsing, Markus Hansson

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9060671db8c498c0987a1831cf0d2591
    https://doi.org/10.1158/1078-0432.c.6524847

    أضف إلى المفضلة
  7. 7
    Figure S1, Figure S2, Figure S3, Figure S4, Figure S5, Figure S6 from Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity

    المؤلفون: Ulrik N. Lassen, Martin Weisser, Birgit Bossenmaier, Francesca Michielin, Celine Adessi, Lori Steiner, Maitram Nguyen, Rajiv Dua, Suzana Vega-Harring, Ian James, Georgina Meneses-Lorente, Maurizio Ceppi, Marlene Thomas, Sabine Wilson, Jan H.M. Schellens, Sang-We Kim, Enriqueta Felip, Antonio Calles, Ji-Youn Han, Stefan Sleijfer, Maja J. De Jonge, Marlies H.G. Langenberg, Martijn P. Lolkema, Andres Cervantes, Tania Fleitas, Alvaro Taus, Maria Martinez-Garcia, Morten Mau-Sorensen, Emile E. Voest, Wolfgang Jacob, Didier Meulendijks

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::135623d1e0a77e3729af54381eb2fbbb
    https://doi.org/10.1158/1078-0432.22468830

    أضف إلى المفضلة
  8. 8
    Effect of capmatinib on the pharmacokinetics of substrates of CYP3A (midazolam) and CYP1A2 (caffeine) in patients with MET-dysregulated solid tumours

    المؤلفون: Xinhui Chen, Nicolas Isambert, Rafael López‐López, Monica Giovannini, Nathalie Pognan, Shruti Kapoor, Michelle Quinlan, Benoit You, Xiaoming Cui, Gholamreza Rahmanzadeh, Morten Mau‐Sorensen

    المصدر: Chen, X, Isambert, N, López-López, R, Giovannini, M, Pognan, N, Kapoor, S, Quinlan, M, You, B, Cui, X, Rahmanzadeh, G & Mau-Sorensen, M 2023, ' Effect of capmatinib on the pharmacokinetics of substrates of CYP3A (midazolam) and CYP1A2 (caffeine) in patients with MET-dysregulated solid tumours ', British Journal of Clinical Pharmacology, vol. 89, no. 3, pp. 1046-1055 . https://doi.org/10.1111/bcp.15544

    مصطلحات موضوعية: Pharmacology, capmatinib, midazolam, DDI, CYP1A2, CYP3A, Pharmacology (medical), caffeine

    وصف الملف: application/pdf

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e751618123039bf7c0a8151dbb589a3e
    https://curis.ku.dk/portal/da/publications/effect-of-capmatinib-on-the-pharmacokinetics-of-substrates-of-cyp3a-midazolam-and-cyp1a2-caffeine-in-patients-with-metdysregulated-solid-tumours(72512f3f-33d1-4b5e-974b-4b8e0ef1d394).html

    أضف إلى المفضلة
  9. 9
    First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumours

    المؤلفون: Debbie Robbrecht, Christiane Jungels, Morten Mau Sorensen, Iben Spanggaard, Ferry Eskens, Signe Ø Fretland, Tormod Kyrre Guren, Philippe Aftimos, David Liberg, Christer Svedman, Lars Thorsson, Neeltje Steeghs, Ahmad Awada

    المساهمون: Medical Oncology

    المصدر: British Journal of Cancer, 126(7), 1010-1017. Nature Publishing Group
    Br J Cancer

    مصطلحات موضوعية: Cancer Research, Oncology, Dose-Response Relationship, Drug, Maximum Tolerated Dose, SDG 3 - Good Health and Well-being, Neoplasms, Antibodies, Monoclonal, Humans, Antineoplastic Agents, Interleukin-1 Receptor Accessory Protein, Article

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d36fe8599641d77b894744932ed8951a
    https://pure.eur.nl/en/publications/85dcc1fa-305e-46a4-889d-c10cef4ff14a

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest
    أضف إلى المفضلة
  10. 10
    Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma

    المؤلفون: Sharon Friedlander, Martin Gutierrez, Tami Rashal, Sharon Shacham, Rachid Baz, Michael R. Savona, John Kuruvilla, Thaddeus J. Unger, Nashat Y. Gabrail, Meagan A. Jacoby, Michael Wang, Peter Martin, Robert W. Carlson, Michael Kauffman, Paul Morten Mau-Sorensen, Jean Richard Saint-Martin, Lynn Savoie, Richard Stone, Ian W. Flinn, Ramiro Garzon

    المصدر: Blood. 129(24)

    مصطلحات موضوعية: 0301 basic medicine, Adult, Male, medicine.medical_specialty, Neutropenia, Anemia, Chronic lymphocytic leukemia, Immunology, Follicular lymphoma, Active Transport, Cell Nucleus, Apoptosis, Biochemistry, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, hemic and lymphatic diseases, Internal medicine, Medicine, Humans, Aged, Aged, 80 and over, Cell Nucleus, Leukopenia, Dose-Response Relationship, Drug, business.industry, Lymphoma, Non-Hodgkin, Cell Biology, Hematology, Middle Aged, Triazoles, medicine.disease, Thrombocytopenia, Lymphoma, Neoplasm Proteins, 030104 developmental biology, Hydrazines, 030220 oncology & carcinogenesis, Mantle cell lymphoma, Female, medicine.symptom, business, Diffuse large B-cell lymphoma, Hyponatremia

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82cc819cd1c3ba17b44743d1d1572bbb
    https://pubmed.ncbi.nlm.nih.gov/32645170

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء